Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) Debt to Equity (2016 - 2025)

Skinvisible's Debt to Equity history spans 15 years, with the latest figure at -$0.0 for Q3 2025.

  • For Q3 2025, Debt to Equity rose 99.82% year-over-year to -$0.0; the TTM value through Sep 2025 reached -$0.0, up 99.82%, while the annual FY2024 figure was -$0.58, 2.17% up from the prior year.
  • Debt to Equity for Q3 2025 was -$0.0 at Skinvisible, up from -$0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at -$0.0 in Q3 2025 and bottomed at -$0.66 in Q1 2023.
  • The 5-year median for Debt to Equity is -$0.11 (2021), against an average of -$0.28.
  • The largest YoY upside for Debt to Equity was 99.82% in 2025 against a maximum downside of 1117.28% in 2025.
  • A 5-year view of Debt to Equity shows it stood at -$0.09 in 2021, then tumbled by 429.45% to -$0.45 in 2022, then tumbled by 32.14% to -$0.6 in 2023, then rose by 2.17% to -$0.58 in 2024, then surged by 99.83% to -$0.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Debt to Equity are -$0.0 (Q3 2025), -$0.0 (Q2 2025), and -$0.57 (Q1 2025).